Arama

EISSN 2148-5607

TJG IS INDEXED IN WEB OF SCIENCE AND PUBMED IMPACT FACTOR: 1.2

Turkish Journal of Gastroenterology

PDF

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 20 results

Ranking

Release Date Sort Sort Article Type

Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome

Oktay YENER, Fikret AKSOY, Mustafa DEMİR, Alp ÖZÇELIK

(Turk J Gastroenterol 2010; 21: 411-415) DOI: 10.4318/tjg.2010.0128

Abstract Full Text ( PDF) Related Articles

Apoptosis in selected liver diseases

Alp KILIÇARSLAN, Alişan KAHRAMAN, Hikmet AKKIZ, Şule YILDIZ MENZİLETOĞLU , Christain D. FINGAS, Guido GERKEN, Ali CANBAY

(Turk J Gastroenterol 2009; 20: 171-179) DOI: 10.4318/tjg.2009.0003

Abstract Full Text ( PDF) Related Articles

A new marker for lipid peroxidation: Serum paraoxonase activity in non-alcoholic steatohepatitis

Mevlüt BAŞKOL, Gülden BAŞKOL , Kemal DENİZ, Ömer ÖZBAKIR, Mehmet YÜCESOY

(Turk J Gastroenterol 2005; 16: 119-123)

Abstract Full Text ( PDF) Related Articles

Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome

Apoptosis in selected liver diseases

A new marker for lipid peroxidation: Serum paraoxonase activity in non-alcoholic steatohepatitis

Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment

L-Carnitine therapy in non-alcoholic steatohepatitis

Obesity and related parameters of non-alcoholic steatohepatitis

Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis

The importance of iron and copper accumulation in the pathogenesis of non-alcoholic steatohepatitis

Nonalcoholic fatty liver disease: Diagnosis, pathogenesis, and management

A comparison of the effects of infliximab, adalimumab, and pentoxifylline on rats with non-alcoholic steatohepatitis

The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters

Determination of certain bacterial groups in gut microbiota and endotoxin levels in patients with nonalcoholic steatohepatitis

Changing in the etiologies and the presentation charactheristics in hepatocellular carcinoma. A single center experience in western Turkey

Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience

Non-alcoholic fatty liver disease: A growing public health problem in Turkey

Histological Characteristics of Non-alcoholic Steatohepatitis in NAFLD Patients With Low Degree of Hepatocyte Apoptosis

Therapeutic Effect of Crocin on the NASH Model by Targeting the Fas Receptor Signaling Pathway

Determining Subclinical Cardiovascular and Cardiac Diseases in Patients with Non-Alcoholic Fatty Liver Disease

Serum Ferritin and Non-alcoholic Fatty Liver Disease: A Meta-analysis and Systematic Review

Liver Fatty Acid-binding Protein Is a More Reliable Biomarker for Liver Injury in Nonalcoholic Steatohepatitis than Other Etiologies of Hepatitis